Yonatan Edel

Ashdod, D, Israel

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.

Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network.

Journal: The Lancet. Haematology

Published: November 28, 2025

Hemoptysis and Epistaxis Caused by Nile Leach, Limnatis nilotica, in the Hypopharyngeal Wall of an Adult Patient in Israel.

Hemoptysis and Epistaxis Caused by Nile Leach, Limnatis nilotica, in the Hypopharyngeal Wall of an Adult Patient in Israel.

Journal: The Israel Medical Association journal : IMAJ

Published: December 18, 2024

Elevated troponin levels in rhabdomyolysis as a predictor of mortality in patients with normal kidney and cardiac function.

Elevated troponin levels in rhabdomyolysis as a predictor of mortality in patients with normal kidney and cardiac function.

Journal: Scientific reports

Published: September 19, 2024

CO2 Laser Matricectomy for the Treatment of Pincer Nail Deformity: A Retrospective Cohort Study.

CO2 Laser Matricectomy for the Treatment of Pincer Nail Deformity: A Retrospective Cohort Study.

Journal: Journal of drugs in dermatology : JDD

Published: November 09, 2023

Ocular and orbital manifestations in VEXAS syndrome.

Ocular and orbital manifestations in VEXAS syndrome.

Journal: Eye (London, England)

Published: August 25, 2023

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab.

Combination treatment of persistent COVID-19 in immunocompromised patients with remdesivir, nirmaltrevir/ritonavir and tixegavimab/cilgavimab.

Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi

Published: June 26, 2023

A 25-Hour Fast Among Quiescent Hereditary Coproporphyria and Variegate Porphyria Patients is Associated With a Low Risk of Complications.

A 25-Hour Fast Among Quiescent Hereditary Coproporphyria and Variegate Porphyria Patients is Associated With a Low Risk of Complications.

Journal: Rambam Maimonides medical journal

Published: January 31, 2023

Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network.

Key terms and definitions in acute porphyrias: Results of an international Delphi consensus led by the European porphyria network.

Journal: Journal of inherited metabolic disease

Published: January 28, 2023

G-CSF-induced ANCA associated glomerulonephritis in the presence of silent membranous "full house nephropathy" in an altruistic bone marrow donor.

G-CSF-induced ANCA associated glomerulonephritis in the presence of silent membranous "full house nephropathy" in an altruistic bone marrow donor.

Journal: Renal failure

Published: August 24, 2022

Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?

Plasma porphyrins among end stage renal disease patients and cutaneous symptoms- is there still an association?

Journal: Molecular genetics and metabolism reports

Published: August 19, 2022

Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study.

Urine soluble triggering receptor expressed on myeloid cells-1 is a novel biomarker for active lupus nephritis: a case-control study.

Journal: Clinical and experimental rheumatology

Published: April 10, 2022

Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug Administration.

Twenty Years of Targeted and Biologic Immunomodulatory Drugs: Postmarketing Modifications of Drug Labels Approved by the US Food and Drug Administration.

Journal: Mayo Clinic proceedings

Published: June 10, 2021

Showing 1-12 of 34

Last Updated: 09/26/2026